4547:TYO
Kissei Pharmaceutical Co Ltd
3 695,00 JP¥
0,00%
(0,00) 1D
8 հոկ, 15:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4547...
Mkt. cap
170,66 մլրդ
Avg. vol.
69,32 հզր
Volume
0,00
Dividend
3,25%
Quarterly dividend
30 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
10,95
52-wk high
5 040 JP¥
52-wk low
3 500 JP¥
EPS
337 JP¥
Shares outstanding
46,72 մլն
No. of employees
2 հզր
Mkt. cap
170,66 մլրդ
Avg. vol.
69,32 հզր
Volume
0,00
Dividend
3,25%
Quarterly dividend
30 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
10,95
52-wk high
5 040 JP¥
52-wk low
3 500 JP¥
EPS
337 JP¥
Shares outstanding
46,72 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Simply Wall Street
·
13 րոպե առաջ
Nebius Group (NBIS) Gains Fresh Analyst Backing As Fair Value Debate Returns
CNBC
·
43 րոպե առաջ
Jim Cramer talks what lead the Dow higher while the Nasdaq sunk
MarketBeat
·
43 րոպե առաջ
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 6,444 Shares of Company Stock
Bloomberg.com
·
1 ժամ առաջ
Tech Stocks to Fall as OpenAI Sinks US Chipmakers: Markets Wrap
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1,79 հզր
Founded09 օգս, 1946 թ.
HeadquartersՄացումոտո, Nagano, Ճապոնիա
Sector-
Websitekissei.co.jp